innovateli.com | January 25, 2018
Trace amounts: Applied DNA Sciences and Canadian pharma supplier TheraCann International will create new technologies to molecular-tag and track legal cannabis supplies around the globe.
By GREGORY ZELLER //
It’s another new high for Applied DNA Sciences.
Just days after introducing a new satellite laboratory in India to service its growing Asian-Pacific customer base, the Stony Brook-based biotech lit up again Thursday, announcing a new contract to develop molecular tracking systems for a worldwide network of legal cannabis supplies.
The two-year, $1 million development and marketing agreement with Canadian supplier TheraCann International Benchmark Corp. – which provides turn-key pharmaceutical solutions through operations in Alberta, Australia, Panama City and Colorado – will create “the first seed-to-sale cannabis tracking system combining molecular tagging and blockchain technologies,” according to Applied DNA.
